That is an advisory-committee proposal, not a final determination, and BPC-157 was never FDA-approved
Peptide AOD 9604 and mechanisms of action in the joint When studies discuss what AOD-9604 is used for, the emphasis is almost always on its effect on cellular metabolism within joint tissues
It inhibits NF-kB, the master transcription factor controlling the inflammatory cascade, and is actively transported into inflamed intestinal cells via the PepT1 transporter
Rodent healing differs from human healing in various ways, and dose extrapolation involves assumptions that may not hold perfectly
But the science gets complicated quickly
It is also, at the blend level, a hypothesis